Skip to content
10-Q

Quarterly Report

Spruce Biosciences, Inc. SPRB

0001193125-25-274234

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 1.07M sh
Shares Diluted Q3 2025 · Sep 30, 2025 563.07K sh
Shares Diluted Q3 2025 · Sep 30, 2025 589.52K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 550.65K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 549.12K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$26.87M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$35.29M
Long Term Debt Q3 2025 · Sep 30, 2025 $0
Long Term Debt Q3 2025 · Dec 31, 2024 $124K
Short Term Debt Q3 2025 · Sep 30, 2025 $539K
Short Term Debt Q3 2025 · Dec 31, 2024 $1.62M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $10.67M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $38.75M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $60.06M
Stockholders Equity Q3 2025 · Sep 30, 2025 $5.39M
Stockholders Equity Q3 2025 · Jun 30, 2025 $13.18M
Stockholders Equity Q3 2025 · Dec 31, 2024 $28.82M
Stockholders Equity Q3 2025 · Sep 30, 2024 $51.64M
Stockholders Equity Q3 2025 · Jun 30, 2024 $59.17M
Stockholders Equity Q3 2025 · Dec 31, 2023 $76.51M
Current Liabilities Q3 2025 · Sep 30, 2025 $9.43M
Current Liabilities Q3 2025 · Dec 31, 2024 $15.25M
Total Liabilities Q3 2025 · Sep 30, 2025 $9.93M
Total Liabilities Q3 2025 · Dec 31, 2024 $16.39M
Current Assets Q3 2025 · Sep 30, 2025 $14.52M
Current Assets Q3 2025 · Dec 31, 2024 $44.21M
Total Assets Q3 2025 · Sep 30, 2025 $15.31M
Total Assets Q3 2025 · Dec 31, 2024 $45.21M
Eps Diluted Q3 2025 · Sep 30, 2025 −$14.58
Eps Diluted Q3 2025 · Sep 30, 2025 −$41.25
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$15.75
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$53.68
Eps Basic Q3 2025 · Sep 30, 2025 −$14.58
Eps Basic Q3 2025 · Sep 30, 2025 −$41.25
Eps Basic restated Q3 2025 · Sep 30, 2024 −$15.75
Eps Basic restated Q3 2025 · Sep 30, 2024 −$53.68
Sga Expense Q3 2025 · Sep 30, 2025 $3.22M
Sga Expense Q3 2025 · Sep 30, 2025 $10M
Sga Expense Q3 2025 · Sep 30, 2024 $3.46M
Sga Expense Q3 2025 · Sep 30, 2024 $11.33M
Rd Expense Q3 2025 · Sep 30, 2025 $5.01M
Rd Expense Q3 2025 · Sep 30, 2025 $15.42M
Rd Expense Q3 2025 · Sep 30, 2024 $6.55M
Rd Expense Q3 2025 · Sep 30, 2024 $24.96M
Net Income Q3 2025 · Sep 30, 2025 −$8.21M
Net Income Q3 2025 · Sep 30, 2025 −$24.32M
Net Income Q3 2025 · Sep 30, 2024 −$8.67M
Net Income Q3 2025 · Sep 30, 2024 −$29.48M
Operating Income Q3 2025 · Sep 30, 2025 −$8.23M
Operating Income Q3 2025 · Sep 30, 2025 −$25.41M
Operating Income Q3 2025 · Sep 30, 2024 −$9.41M
Operating Income Q3 2025 · Sep 30, 2024 −$32.08M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2024 $602K
Revenue Q3 2025 · Sep 30, 2024 $4.21M